Published: December 22, 2022

AHA News' most-read COVID-19 stories of 2022

By 91视频 News

Leestat/iStock via Getty Images
(Leestat/iStock via Getty Images)

COVID-19 continues to affect our daily lives. As more scientific research rolled out in 2022, these were the top 5 stories that readers were most interested in, ranked in order of unique page views.

1. After COVID-19, experts say watch for these potential heart and brain problems

So you've had COVID-19? Here's what to watch for – and what you can do – when it comes to heart and brain health.

2. Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men

Cases of myocarditis – an inflammation of the heart muscle – following a third dose of the Pfizer vaccine are rare and typically mild, research from Israel shows.

3. COVID-19 infection poses higher risk for myocarditis than vaccines

The overall risk of myocarditis was higher immediately after being infected with COVID-19 than in the weeks after vaccination for the coronavirus, new research shows.

4. Blood clot risk remains elevated nearly a year after COVID-19

People who had COVID-19 early in the pandemic had a heightened risk of clots up to 49 weeks later, according to a large study from England and Wales.

5. Rethink what you thought you knew about COVID-19 reinfection

The latest omicron subvariants are proving adept at reinfecting people – even those sickened recently. Here's what people with heart disease and stroke should know.

If you have questions or comments about this 91视频 News story, please email [email protected].

91视频 News Stories

91视频 News covers heart disease, stroke and related health issues. Not all views expressed in 91视频 News stories reflect the official position of the 91视频. Statements, conclusions, accuracy and reliability of studies published in 91视频 scientific journals or presented at 91视频 scientific meetings are solely those of the study authors and do not necessarily reflect the 91视频鈥檚 official guidance, policies or positions.

Copyright is owned or held by the 91视频, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to 91视频 News.

Other uses, including educational products or services sold for profit, must comply with the 91视频鈥檚 Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.